Original news and analysis on international IP policy
The Medicines Patent Pool (MPP) has announced a licence agreement with pharmaceutical manufacturer AbbVie to allow the production of cheaper, more accessible paediatric versions of two HIV medicines.
The 2014 edition of an independent ranking of leading pharmaceutical companies' efforts to help developing countries released today found new initiatives undertaken in the past two years. But it said corruption and insufficient disclosure of existing patents continue to plague the industry.
The World Health Organization Pandemic Influenza Preparedness (PIP) Framework is at risk due to some companies not fulfilling their obligations, a new WHO report says.
Proposals for products to help fight Ebola are coming in to the World Health Organization, but few look promising so far, an official said today. Meanwhile, efforts are on to establish testing sites for potential products, and thinking is still in the early stages on intellectual property rights for new drugs in development.
NEW YORK - Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.
The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.
A high-level meeting convened by the World Health Organization yesterday on the issue of access to and financing of Ebola vaccines resulted in a set of commitments, though not with sufficient urgency for those working on the ground. The pharmaceutical industry committed to scale up production, while donors pledged funds without disclosing how deep their pockets might be.
PARIS –Life sciences stakeholders at a recent conference explored matters associated with market access in the BRICS (Brazil, Russia, India, China, South Africa) and in the Middle East and North Africa regions.
World Trade Organization Director General Roberto Azevêdo this week hailed WTO’s intellectual property agreement, saying the past two decades show it provides a balanced multilateral foundation for the growth of trade in knowledge-rich products and services.
Today, the World Health Organization gave a press briefing to update journalists on what to expect in the near future on Ebola treatments and vaccines.